default author photo

Yehong Kuang

Central South University - Department of Dermatology

Changsha

China

  • Central South University - Department of Dermatology

SCHOLARLY PAPERS

3

DOWNLOADS

260

TOTAL CITATIONS

1

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Topical VX-509 Attenuates Psoriatic Inflammation Through the STAT3/FABP5 Pathway in Keratinocytes

Downloads 132 (551,165)

Topical VX-509 Attenuates Psoriatic Inflammation Through the STAT3/FABP5 Pathway in Keratinocytes

Number of pages: 39 Posted: 08 Feb 2022
Bei Yan, Panpan Liu, Xiaoqing Yi, Jie Li, Nian Liu, Wu Zhu, Yehong Kuang, Xiang Chen and Cong Peng
Central South University - Department of Dermatology, Central South University - Department of Dermatology, Central South University - Department of Dermatology, Central South University - Department of Dermatology, Central South University - Department of Dermatology, Central South University - Department of Dermatology, Central South University - Department of Dermatology, Central South University - Department of Dermatology and Central South University - Department of Dermatology
Downloads 45 (1,144,483)

Abstract:

Loading...

Psoriasis, VX-509, FABP5, IL-22, STAT3

Topical VX-509 Attenuates Psoriatic Inflammation Through the STAT3/FABP5 Pathway in Keratinocytes

Number of pages: 46 Posted: 12 May 2022
Cong Peng, Bei Yan, Panpan Liu, Xiaoqing Yi, Jie Li, Nian Liu, Wu Zhu, Yehong Kuang and Xiang Chen
Central South University - Department of Dermatology, Central South University - Department of Dermatology, Central South University - Department of Dermatology, Central South University - Department of Dermatology, Central South University - Department of Dermatology, Central South University - Department of Dermatology, Central South University - Department of Dermatology, Central South University - Department of Dermatology and Central South University - Department of Dermatology
Downloads 45 (1,144,483)

Abstract:

Loading...

Psoriasis, Topical application treatment, VX-509, FABP5, IL-22, STAT3

Topical Vx-509 Attenuates Psoriatic Inflammation Through the Stat3/Fabp5 Pathway in Keratinocytes

Number of pages: 34 Posted: 21 Feb 2022
Cong Peng, Bei Yan, Panpan Liu, Xiaoqing Yi, Jie Li, Nian Liu, Wu Zhu, Yehong Kuang and Xiang Chen
Central South University - Department of Dermatology, Central South University - Department of Dermatology, Central South University - Department of Dermatology, Central South University - Department of Dermatology, Central South University - Department of Dermatology, Central South University - Department of Dermatology, Central South University - Department of Dermatology, Central South University - Department of Dermatology and Central South University - Department of Dermatology
Downloads 42 (1,183,247)

Abstract:

Loading...

Psoriasis, VX-509, FABP5, IL-22, STAT3

2.

AMPK Activation, A Target of Metformin, is Associated with the Risk of Psoriasis and its Comorbidities in the UK Biobank: A Mendelian Randomization Study

Number of pages: 21 Posted: 13 Jun 2022
Yi Xiao, Guowei Zhou, Danrong Jing, zhenwei Tang, Cong Peng, Yehong Kuang, Wu Zhu, Xiang Chen, Hong Liu and Minxue Shen
Central South University - Department of Dermatology, Central South University - Department of Dermatology, Central South University - Department of Dermatology, Central South University - Department of Dermatology, Central South University - Department of Dermatology, Central South University - Department of Dermatology, Central South University - Department of Dermatology, Central South University - Department of Dermatology, Central South University - Hunan Key Laboratory of Skin Cancer and Psoriasis and Central South University - Department of Social Medicine and Health Management
Downloads 76 (837,727)

Abstract:

Loading...

Keywords: AMPK, psoriasis, cardiovascular disease, Mendelian randomization, metformin, UK Biobank

3.

A Randomized, Double-Blind Phase III Study to Demonstrate the Clinical Similarity of Biosimilar SCT630 to Reference Adalimumab in Chinese Patients with Moderate to Severe Plaque Psoriasis

Number of pages: 27 Posted: 01 Jun 2022
Chen Yu, Gang Wang, Furen Zhang, Yangfeng Ding, Yumei Li, Yi Zhao, Jun Gu, Shuping Guo, Weili Pan, Hongzhong Jin, Qing Sun, Xiaojing Kang, Qinping Yang, Xian Jiang, Zhiqiang Song, Qianjin Lu, Xiaowen Pang, Yehong Kuang, Danqi Deng, Yuzhen Li, Chunlei Zhang, Juan Tao, Liangzhi Xie, Yan Wang and Jieying Wang
Government of the People's Republic of China - Xijing Hospital, Government of the People's Republic of China - Xijing Hospital, Shandong First Medical University - Shandong Provincial Hospital, Tongji University - Shanghai Skin Disease Hospital, Jiangsu University - Affiliated Hospital, Tsinghua University - Beijing Tsinghua Changgung Hospital, Naval Medical University - Changhai Hospital, Shanxi Medical University - First Hospital, People's Hospital of Hangzhou Medical College - Zhejiang Provincial People's Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Shandong University - Qilu Hospital, People's Hospital of Xinjiang Uygur Autonomous Region, Fudan University - Huashan Hospital, Sichuan University - West China Hospital, Southwest University - Southwest Hospital, Central South University - Second Xiangya Hospital, Government of the People's Republic of China - Air Force Medical Center, Central South University - Department of Dermatology, Kunming Medical University - Second Affiliated Hospital, Harbin Medical University - Second Affiliated Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Huazhong University of Science and Technology - Union Hospital, Sinocelltech Ltd., Sinocelltech Ltd. and Sinocelltech Ltd.
Downloads 52 (1,074,648)
Citation 1

Abstract:

Loading...

adalimumab, SCT630, plaque psoriasis